期刊文献+

n-6/n-3多不饱和脂肪酸对子宫内膜癌Ishikawa细胞增殖的影响

The effects and mechanisms of different n -6/n -3 polyunsaturated fatty acid ratio on endometrial carcinoma cells
下载PDF
导出
摘要 目的探讨n-6/n-3多不饱和脂肪酸(PUFAs)对子宫内膜癌Ishikawa细胞增殖及细胞中哺乳动物雷帕霉素靶蛋白(mammMiantargetofrapamycin,mTOR)、血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)表达的影响。方法用不同比例的n-6/n-3PUFAs处理细胞,MTr法检测细胞增殖能力变化;RT—PCR检测细胞mTOR、VEGF的mRNA表达情况。结果单纯n-6PUFAs和10:1n-6/n-3PUFAs能够明显促进Ishikawa细胞增殖,mTOR、VEGF的mRNA表达增加(P〈0.05);单纯n-3PUFAs和1:1n-6/n-3PUFAs则显著抑制细胞增殖,同时使VEGF的mRNA表达下降(P〈0.05);mTOR与VEGFmRNA的表达呈正相关(r=0.94,P〈0.05)。结论n-6/n-3PUFAs可能通过影响mTOR信号调节VEGF表达,从而对Ishikawa细胞增殖产生影响。 Objective To explore the effects and mechanisms of different n - 6/n - 3 polyunsaturated fatty acids (PUFAs) ratio on endometrial carcinoma Ishikawa cells. Methods Ishikawa cells were treated with n -6 PUFAs, or n - 3 PUFAs, or the mixture of n - 6/n - 3 PUFAs at ratio of 1 : 1 and 10:1. The cell proliferation capacity was detected by MTF, and the expressions of mTOR, VEGF mRNA were tested by RT - PCR respectively. Results n - 6 PUFAs and 10:1 n -6/n -3 PUFAs obviously promoted cell proliferation and up -regulated the expression of mTOR,VEGF mRNA. n- 3 PUFAs and 1:1 n -6/n- 3 PUFAs greatly repressed cell proliferation and down -regulated roTOR, VEGF mRNA expression. There was significant correlation between mTOR and VEGF in Ishikawa cell ( r = 0.94, P 〈 O. 05 ). Conclu- sion n -6/n -3 PUFAs at different ratios has different effects in endometrial carcinoma Ishikawa cells through working on mTOR signal to regulate VEGF expression probably.
作者 曾田 陆晓媛
出处 《徐州医学院学报》 CAS 2013年第1期20-22,共3页 Acta Academiae Medicinae Xuzhou
基金 徐州医学院研究生科技创新计划(XYLC-1223)
关键词 多不饱和脂肪酸 ISHIKAWA细胞 哺乳动物雷帕霉素靶蛋白 血管内皮生长因子 polyunsaturated fatty acids endometrial carcinoma Ishikawa cells mammalian target of rapamycin vascular endothelial growth factor
  • 相关文献

参考文献8

  • 1Gerber M. Background review paper on total fat,fatty acid intake and cancers[J].Annals of Nutrition and Metabolism,2009,(1-3):140-161.
  • 2Parkin DM,Bray F,Ferlay J. Global cancer statistics,2002[J].CA:A Cancer Journal for Clinicians,2005,(02):74-108.
  • 3Calder PC. Fatty acids and inflammation:the cutting edge between food and pharma[J].European Journal of Pharmacology,2011,(Suppl 1):S50-S58.
  • 4陈洪菊,唐彬秩,屈艺,母得志.mTOR信号通路调节HIF-1α及VEGF[J].生命的化学,2011,31(6):838-843. 被引量:14
  • 5Wullschleger S,Loewith R,Hall MN. TOR signaling in growth and metabolism[J].Cell,2006,(03):471-484.
  • 6Yokoyama Y,Sato S,Futagami M. Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma[J].Gynecologic Oncology,2000,(03):413-418.
  • 7Fujimoto J,Ichigo S,Hirose R. Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers[J].Cancer Letters,1998,(01):15-22.
  • 8Richter JD,Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins[J].Nature,2005,(7025):477-480.

二级参考文献4

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部